A prescription form of CBD is approved for treating seizure disorders (such as epilepsy). While CBD is also used for conditions like anxiety, pain, dystonia (a muscle disorder), Parkinson's disease, Crohn's disease, and more, there is insufficient scientific evidence to support its effectiveness for these uses.
In 2018, laws were passed that legalized the sale of hemp and hemp-derived products in the US. However, this does not mean all CBD products made from hemp are automatically legal. Since CBD is an FDA-approved prescription medication, it cannot be legally added to food or dietary supplements. Instead, CBD can only be included in "cosmetic" products. Despite this, there are still many CBD products on the market labeled as dietary supplements, and the actual amount of CBD in these products may not always match what is listed on the label.
Likely Effective For:
Seizure Disorder (Epilepsy): The prescription CBD product Epidiolex (by GW Pharmaceuticals) is FDA-approved to treat seizures associated with Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex. It is still uncertain whether other forms of CBD are effective for seizures, so it's best to use the FDA-approved prescription option for this condition.
While there is growing interest in using CBD for various other health issues, there isn't enough reliable evidence to confirm its effectiveness for these conditions.
Multiple Sclerosis (MS): A prescription nasal spray product, Sativex (by GW Pharmaceuticals), which combines both 9-delta-tetrahydrocannabinol (THC) and cannabidiol, has been shown to effectively reduce pain, muscle tightness, and frequency of urination in people with MS. This product is available in over 25 countries outside of the United States. However, when used alone, cannabidiol has inconsistent evidence regarding its effectiveness for MS symptoms. Some early studies suggest that a cannabidiol spray taken under the tongue may help alleviate pain and muscle tightness, but it does not seem to improve muscle spasms, fatigue, bladder control, mobility, or overall quality of life for MS patients.
A prescription form of CBD is approved for treating seizure disorders (such as epilepsy). While CBD is also used for conditions like anxiety, pain, dystonia (a muscle disorder), Parkinson's disease, Crohn's disease, and more, there is insufficient scientific evidence to support its effectiveness for these uses. In 2018, laws were passed that legalized the sale […]
Jan 08, 2025
"Wishing all our valued partners, clients, and colleagues a Merry Christmas and a joyful holiday season from the VPLUS team! May the new year bring success, growth, and continued collaboration."
Dec 18, 2024
The lung’s delicate surfactant layer is of critical importance to the organ’s overall physiology and innate immune function. Both alveolar type II cells and alveolar macrophages are the principal subsets that maintain and catabolize surfactant at the liquid-air interface. Our study reveals that ENDS exposure disrupts both the lipid and protein components of pulmonary surfactant, […]
Dec 12, 2024
Neurodegenerative diseases leading to Parkinson's disease (PD) and Alzheimer's disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]
Dec 05, 2024
Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg CBD per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by […]
Nov 26, 2024